Since metabolic reprogramming is now recognized as a cancer hallmark [30], we investigated further the effect of MR and RAR signalling on glycolysis and oxidative phosphorylation in breast cancer cells by looking at the expression of key genes involved in the regulation of glycolysis and oxidative phosphorylation. The gene discussed is NR3C2; the disease is breast cancer.